Innovative Regenerative Medicine Elevian specializes in developing therapies that promote tissue recovery and regeneration, targeting stroke treatment and age-related diseases, indicating a market for advanced regenerative medicine solutions.
Strong Funding Backing With a $40 million Series A funding round led by Prime Movers Lab and seed funding of $5.5 million, Elevian exhibits robust investor confidence, suggesting potential for continued growth and increased demand for their innovative therapies.
Research and Development Focus The company's focus on regenerative proteins and partnerships with academic institutions such as Harvard indicate a pipeline of cutting-edge therapeutics, opening opportunities for collaborations with research institutions and biotech partners.
Niche Market Position Operating within the niche of aging-related disease treatment, Elevian presents opportunities to target healthcare providers, biotech companies, and insurance companies interested in preventative and regenerative therapies.
Emerging Market Presence As a relatively small company with 11-50 employees and projected revenues up to $25 million, Elevian offers personalized partnership and licensing opportunities for organizations seeking to expand into the regenerative medicine space.
$25M$50M
$100M$250M
$1M$10M
$10M$25M
$10M$25M
$1M$10M
$1M$10M
$1M$10MElevian, Inc. uses 8 technology products and services including Tumblr, Open Graph, Webpack, and more. Explore Elevian, Inc.'s tech stack below.
| Elevian, Inc. Email Formats | Percentage |
| First.Last@elevian.com | 37% |
| First@elevian.com | 22% |
| Middle@elevian.com | 4% |
| First.Last@elevian.com | 37% |
Biotechnology ResearchMassachusetts, United States2-10 Employees
At Elevian, we are developing new medicines that promote recovery and regeneration. Our lead program is a recombinant protein for the treatment of stroke in the days following the event, for which there are currently no viable treatments. By promoting regeneration, Elevian’s medicines have the potential to treat and prevent many aging-associated diseases.
Company Overview
Media & News
Funding & FinancialsElevian, Inc. has raised a total of $40M of funding over 5 rounds. Their latest funding round was raised on Sep 16, 2021 in the amount of $40M.
Elevian, Inc.'s revenue is estimated to be in the range of $1M$10M
Funding & FinancialsElevian, Inc. has raised a total of $40M of funding over 5 rounds. Their latest funding round was raised on Sep 16, 2021 in the amount of $40M.
Elevian, Inc.'s revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com